title: The metabolite N-4-methoxyphenylretinamide is a major determinant of fenretinide induced decline of plasma insulin-like growth factor-1.
authors.forename: R
authors.initials: R
authors.lastname: Torrisi
authors.forename: F
authors.initials: F
authors.lastname: Pensa
authors.forename: V
authors.initials: V
authors.lastname: Fontana
authors.forename: A
authors.initials: A
authors.lastname: Costa
authors.forename: A
authors.initials: A
authors.lastname: Decensi
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D001943:Breast Neoplasms / Q000097:blood*; D005260:Female; D017313:Fenretinide / Q000494:pharmacology*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000187:drug effects*; D008875:Middle Aged; D014212:Tretinoin / Q000031:analogs & derivatives* / Q000097:blood
chemical_list: D017313:Fenretinide; D014212:Tretinoin; D007334:Insulin-Like Growth Factor I; C058346:N-(4-methoxyphenyl)retinamide